109 related articles for article (PubMed ID: 18039562)
1. Enhanced nasal absorption of hydrophilic markers after dosing with AT1002, a tight junction modulator.
Song KH; Fasano A; Eddington ND
Eur J Pharm Biopharm; 2008 May; 69(1):231-7. PubMed ID: 18039562
[TBL] [Abstract][Full Text] [Related]
2. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
Song KH; Fasano A; Eddington ND
Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
[TBL] [Abstract][Full Text] [Related]
3. Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery.
Song KH; Kim SB; Shim CK; Chung SJ; Kim DD; Rhee SK; Choi GJ; Kim CH; Kim K
Drug Des Devel Ther; 2015; 9():1815-23. PubMed ID: 25848218
[TBL] [Abstract][Full Text] [Related]
4. The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.
Song KH; Eddington ND
J Pharm Pharmacol; 2012 Jan; 64(1):30-9. PubMed ID: 22150669
[TBL] [Abstract][Full Text] [Related]
5. The influence of stabilizer and bioadhesive polymer on the permeation-enhancing effect of AT1002 in the nasal delivery of a paracellular marker.
Song KH; Eddington ND
Arch Pharm Res; 2012 Feb; 35(2):359-66. PubMed ID: 22370791
[TBL] [Abstract][Full Text] [Related]
6. The impact of DeltaG on the oral bioavailability of low bioavailable therapeutic agents.
Salama NN; Fasano A; Thakar M; Eddington ND
J Pharmacol Exp Ther; 2005 Jan; 312(1):199-205. PubMed ID: 15448170
[TBL] [Abstract][Full Text] [Related]
7. The impact of AT1002 on the delivery of ritonavir in the presence of bioadhesive polymer, carrageenan.
Song KH; Eddington ND
Arch Pharm Res; 2012 May; 35(5):937-43. PubMed ID: 22644862
[TBL] [Abstract][Full Text] [Related]
8. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
Motlekar NA; Fasano A; Wachtel MS; Youan BB
J Drug Target; 2006 Jun; 14(5):321-9. PubMed ID: 16882552
[TBL] [Abstract][Full Text] [Related]
9. The effect of delta G on the transport and oral absorption of macromolecules.
Salama NN; Fasano A; Thakar M; Eddington ND
J Pharm Sci; 2004 May; 93(5):1310-9. PubMed ID: 15067707
[TBL] [Abstract][Full Text] [Related]
10. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
11. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
12. Alkanoylsucroses in nasal delivery of low molecular weight heparins: in-vivo absorption and reversibility studies in rats.
Yang T; Mustafa F; Ahsan F
J Pharm Pharmacol; 2004 Jan; 56(1):53-60. PubMed ID: 14980001
[TBL] [Abstract][Full Text] [Related]
13. Tight junction modulation and its relationship to drug delivery.
Salama NN; Eddington ND; Fasano A
Adv Drug Deliv Rev; 2006 Apr; 58(1):15-28. PubMed ID: 16517003
[TBL] [Abstract][Full Text] [Related]
14. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
Preston E; Slinn J; Vinokourov I; Stanimirovic D
J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits.
Kaur P; Kim K
Int J Pharm; 2008 Nov; 364(1):27-35. PubMed ID: 18760341
[TBL] [Abstract][Full Text] [Related]
16. Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides.
He YL; Murby S; Warhurst G; Gifford L; Walker D; Ayrton J; Eastmond R; Rowland M
J Pharm Sci; 1998 May; 87(5):626-33. PubMed ID: 9572915
[TBL] [Abstract][Full Text] [Related]
17. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
Uchida T; Kanazawa T; Takashima Y; Okada H
Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
[TBL] [Abstract][Full Text] [Related]
18. ADME investigations of unnatural peptides: distribution of a 14C-labeled beta 3-octaarginine in rats.
Weiss HM; Wirz B; Schweitzer A; Amstutz R; Rodriguez Perez MI; Andres H; Metz Y; Gardiner J; Seebach D
Chem Biodivers; 2007 Jul; 4(7):1413-37. PubMed ID: 17638323
[TBL] [Abstract][Full Text] [Related]
19. [Advances in study of novel absorption enhancers based on tight junctions].
Kang A; Liang Y; Hao HP; Xie L; Wang GJ
Yao Xue Xue Bao; 2007 Nov; 42(11):1122-8. PubMed ID: 18300465
[TBL] [Abstract][Full Text] [Related]
20. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
